Introduction
The well-established mechanism of action of the cytotoxic drug cisplatin is the alteration of the secondary structure of DNA via coordination to the N7 atom of a guanine or an adenine base, which requires its prior aquation in the cell to generate the more reactive aqua complexes [1, 2] . In general, aquation can be an important activation step for transition metal complexes prior to their coordination to biomolecules [3] . Certain , where XY is a bidentate chelating ligand and Z is a leaving group, exhibit promising cytotoxic activity against a variety of cancer cell lines, including cisplatin-resistant cells [4, 5] . The nature of the arene, the chelating ligand and the leaving group can have a major influence on the rates of activation (towards hydrolysis and/or binding to biomolecules) as well as on the cytotoxic activity [6, 7] . It appears that the presence of a more hydrophobic arene ligand along with a single ligand-exchange site is often associated with significant anticancer activity. Blocking ligand-exchange reactions in the remaining two coordination sites can usually be achieved by coordination of a stable bidentate ligand; in this regard, particularly effective are those ligands containing N,N 0 heterocyclic groups [8] [9] [10] . In this work, we have studied and contrasted the chemical reactivity of a series of organometallic Ru II complexes of the type [(g 6 -arene)Ru(N,N 0 )X][PF 6 ] containing an N,N 0 chelating ligand, as well as various arenes, and different halides (X). Their aqueous solution chemistry and the nucleobase binding to 9-ethylguanine (9-EtG) and 9-ethyladenine (9-EtA) were investigated. Their potential as cytotoxic agents was explored not only by determining IC 50 values with regard to A2780 (human ovarian), A2780cis (human ovarian cisplatin resistant), A549 (human lung) or HCT116 (human colon) cancer cell lines but also by studying DNA interactions in cell-free media. c-Glutamyl-cysteinyl-glycine (glutathione, GSH) coordination to Pt II is known to inhibit DNA binding, contributing to cisplatin resistance in tumour cells [11] [12] [13] , and depending on its relative concentration [14, 15] , it can both facilitate and inhibit ruthenium interactions with DNA [16] . Reactions of GSH with a representative inactive Ru II arene complex (1; Fig. 1 ) in aqueous solution at 310 K were therefore investigated to establish whether GSH may play a role in the activity of this family of complexes.
Materials and methods

Materials
RuCl 3 Á3H 2 O was acquired from Precious Metals Online and used as received. 2,2 0 -Bipyrimidine (bpm), 1,10-phenanthroline (phen), 1,10-phenanthroline-5,6-dione (phendio), Fig. 1 General structures of the complexes studied in this work, synthesized as PF 6 salts 4,7-diphenyl-1,10-phenanthroline (bathophen), 9-EtG, 9-EtA and KPF 6 were obtained from Sigma-Aldrich. KBr and KI (reagent grade) were obtained from Fisher. The Ru II arene precursor dimers [(g 6 -arene)RuX 2 ] 2 , where arene is paracymene (p-cym), biphenyl (bip), hexamethylbenzene (hmb), indane (ind) or tetrahydronaphthalene (thn) and X is Cl, Br or I, were synthesized according to a previously reported method [17] [18] [19] [20] . The dimer [(g 6 -etb)RuCl 2 ] 2 , where etb is ethyl benzoate, was synthesized following a literature procedure [21] . The solvents used for UV-vis absorption spectroscopy were dry MeOH (reagent grade) and deionized water. For NMR spectroscopy, the solvents used were acetone-d 6 , dimethyl-d 6 sulfoxide, MeOH-d 4 and D 2 O obtained from Aldrich. All chemicals were used without further purification. Cisplatin was obtained from Sigma-Aldrich (Prague, Czech Republic). Chloridodiethylenetriamineplatinum(II) chloride was a generous gift from Giovanni Natile (University of Bari). Restriction endonucleases NdeI and HpaI were purchased from New England Biolabs. Acrylamide, bisacrylamide and ethidium bromide were obtained from Merck (Darmstadt, Germany). Agarose was purchased from FMC BioProducts (Rockland, ME, USA). Radioactive reagents were obtained from Amersham (Arlington Heights, IL, USA). Stock aqueous solutions of metal complexes (5 9 10 -4 M) for the biophysical and biochemical studies were filtered and stored at room temperature in the dark. The concentrations of ruthenium or platinum in the stock solutions were determined by flameless atomic absorption spectrometry (FAAS). Calf thymus DNA (CT-DNA; 42 % G ? C, mean molecular mass approximately 2 9 10 7 ) was also prepared and characterized as described previously [22, 23] . pSP73KB (2,455-bp) plasmid was isolated according to standard procedures [32, 33] .
Synthesis of ruthenium complexes
Complexes [(g 6 -arene)Ru(N,N 0 )X][PF 6 ], where arene is p-cym, bip, etb, ind, hmb or thn, N,N 0 is bpm, phen, phendio or bathophen and X is Cl, Br or I were synthesized as previously described [6, 7] . Typically, 2 mol equiv of the N,N 0 chelating ligand and 2 mol equiv of KPF 6 were added to a solution of 1 mol equiv of the appropriate Ru II arene dimer in dry MeOH (20 mL) with constant stirring over 48 h, after which the precipitate formed was collected by filtration. The remaining solution was concentrated and portions of Et 2 O were added to further precipitate the product, which was again collected by filtration. Both solids were combined and washed with portions of Et 2 O and MeOH and dried overnight under a vacuum, resulting in microcrystalline products. Details of the amounts of reactants, volumes of solvents, colour changes and nature of the products are given in the electronic supplementary material for the individual reactions, as well as any variations in the synthetic procedure. Some complexes were also characterized by 13 C NMR spectroscopy.
X-ray crystallography
Diffraction data were collected either with an Oxford Diffraction Gemini four-circle system with a Ruby CCD area detector or with a Siemens SMART three-circle system with a CCD area detector equipped with an Oxford Cryosystems cooler. All structures were refined by fullmatrix least squares against F 2 using SHELXL 97 [24] . The structures of complexes 3, 4, 6, 7 and 14 were solved by direct methods using SHELXS [25, 26] (TREF), with additional light atoms found by Fourier methods. Hydrogen atoms were added at calculated positions and refined using a riding model with freely rotating methyl groups. Anisotropic displacement parameters were used for all non-hydrogen atoms; hydrogen atoms were given isotropic displacement parameters equal to 1.2 (or 1.5 for methyl hydrogen atoms) times the equivalent isotropic displacement parameter of the atom to which the hydrogen atom is attached.
NMR spectroscopy 1 H and 13 C NMR spectra were acquired in 5-mm NMR tubes at 298 K (unless otherwise stated) using Bruker AV-400, DRX-500, AV III 600 or AV II 700 NMR spectrometers. All data processing was done using XWIN-NMR version 3.6 (Bruker UK). 1 H NMR chemical shifts were internally referenced to tetramethylsilane via 1,4-dioxane (d = 3.71) or residual MeOH (d = 3.31). One-dimensional spectra were recorded using standard pulse sequences. Typically, data were acquired with 128 transients into 16,384 data points over a spectral width of 14 ppm. Two-dimensional correlation spectroscopy or total correlation spectroscopy and nuclear Overhauser enhancement spectroscopy (NOESY) spectra were recorded using standard pulse-pulse sequences. Typically, data were acquired with 72 transients into 1,048576 data points over a spectral width of 14 ppm using a relaxation delay of 1.5 s and a mixing time of 0.06 s.
Elemental analysis
Elemental analyses were performed by Exeter Analytical (UK) using an CE-440 elemental analyser.
High-resolution electrospray mass spectrometry High-resolution mass spectrometry (HR-MS) data were obtained with a Bruker MaXis UHR-TOF instrument. All the samples were analysed by positive-ion electrospray ionization mass spectra. Samples were prepared in either 100 % H 2 O or 95 % MeOH/5 % H 2 O mixture and were typically injected at 2 lL min -1 . The settings were as follows: nebulizer gas (N 2 ) 0.4 bar, drying gas (N 2 ) 4 L min -1 and drying temperature 453 K, funnel RF 200V,  multiple RF 200, quadrupole ion energy 4 eV, collision  cell 5 eV, ion cooler RF settings, ramp from 50 to 250 V,  unless otherwise stated. UV-vis absorption spectroscopy UV-vis absorption spectra were recorded with a Cary 50 Bio spectrophotometer with a PTP1 Peltier temperature controller or with a Beckman DU 7400 UV-vis spectrophotometer equipped with a thermoelectrically controlled cell holder, in 1 cm path length quartz cells (600 lL). Spectra were recorded at 310 K in deionized water from 220 to 800 nm and were processed using UV WinLab for Windows 95. [28, 29] . Uncontracted Slatertype orbital basis sets comprised a triple-f plus 5p orbital set on ruthenium with double-f plus polarization on all other atoms. Default convergence criteria were applied for self-consistent field and Cartesian geometry optimizations. For optimizations in internal coordinates, in particular transition state searches, the angle threshold was set to 1.5°( default of 0.5°). This criterion was relaxed because of the long bond lengths at the transition states, which make it harder to define torsional terms accurately. The same problem occurs for reactant and product species because the respective entering and leaving groups are included in the calculation, and their relatively weak interaction with the rest of the complex again leads to less well defined torsional terms. However, the energetic consequences of relaxing the angle constraints are negligible. The ADF program reported a single negative eigenvalue in the Hessian matrix for all transition state optimizations. A representative transition state was confirmed as a first-order saddle point with frequency calculations as described earlier [30, 31] . The conductor-like screening model (COSMO) as implemented in ADF was used to simulate the aqueous environment with e = 78.4, probe radius 1.9 Å and the ND parameter, which controls integration accuracy, set to 4 (default 3). The atomic radii used were 1.950 Å for ruthenium, 1.517 Å for oxygen, 1.700 Å for carbon, 1.608 Å for nitrogen, 1.350 Å for hydrogen, 1.725 Å for chlorine, 1.850 Å for bromine and 1.967 Å or iodine.
DFT-geometry optimization of DNA model nucleobase adducts Geometry optimizations were performed for the 9-EtG and 9-EtA adducts of [(g 6 
(11-9-EtA), [(g 6 -p-cym)Ru(bathophen)(9-EtG-N7)] 2? (13-9-EtG) and [(g 6 -p-cym)Ru(bathophen)(9-EtA-N7)] 2? (13-9-EtA) for the free 9-EtG and 9-EtA molecules and for the Ru II arene cations without the bound 9-EtG or 9-EtA. The energies of the separate optimized fragments were subtracted from the energy of the whole Ru II arene nucleobase adducts to obtain the total binding energy of 9-EtG and 9-EtA in each complex. DNA transcription by RNA polymerase in vitro Transcription of the (NdeI/HpaI) restriction fragment of pSP73KB DNA with T7 RNA polymerase and electrophoretic analysis of the transcripts were performed as previously described [32, 33] . The DNA concentration used was 3.9 9 10 -5 M (0.0125 lg/lL) (0.25 lg per sample) (related to the monomeric nucleotide content) and the concentration of complexes was approximately 1.17 9 10 -6 M.
Unwinding of negatively supercoiled DNA Unwinding of closed circular supercoiled pUC19 plasmid DNA was assayed by an agarose gel mobility shift assay [34] . The mean unwinding angle can be calculated from the equation U = -18r/r b (c), where r is the superhelical density (representing the number of turns added or removed relative to the total number of turns in the relaxed plasmid, indicating the level of supercoiling), and r b (c) is the r b value at which the supercoiled and nicked forms comigrate [34] . Samples of plasmid DNA at a concentration of 1.0 9 10 -4 M (0.5 lg per sample) (related to the monomeric nucleotide content) were incubated with the Ru II arene complexes at 310 K for 24 h. All samples were precipitated by ethanol and redissolved in the tris(hydroxymethyl)aminomethane-acetate/EDTA, pH 8.0 buffer to remove free, unbound Ru II arene complexes. One aliquot of the precipitated sample was subjected to electrophoresis on 1 % agarose gels running at 298 K with tris(hydroxymethyl)aminomethane-acetate/EDTA, pH 8.0 buffer, and the voltage was set at 25 V. The gels were then stained with ethidium bromide, followed by photography with a transilluminator. Electron absorption spectrometry and FAAS were used for the determination of r b values.
Circular dichroism
Isothermal circular dichroism (CD) spectra of CT-DNA modified by the Ru II arene complexes at a concentration of 3.3 9 10 -4 M were recorded at 298 K in 10 mM NaClO 4 using a JASCO J-720 spectropolarimeter equipped with a thermoelectrically controlled cell holder. The cell path length was 1 cm. CD spectra were recorded in the range from 230 to 600 nm in 0.5-nm increments with an averaging time of 0.5 s.
Flow linear dichroism
Flow linear dichroism (LD) spectra were collected by using a flow Couette cell in a JASCO J-720 spectropolarimeter adapted for LD measurements. The flow cell consists of a fixed outer cylinder and a rotating solid quartz inner cylinder, separated by a gap of 0.5 mm, giving a total path length of 1 mm. LD spectra of DNA at a concentration of 3.3 9 10 -4 M modified by the Ru II arene complexes were recorded at 298 K in 10 mM NaClO 4 .
Other physical methods
The FAAS measurements were performed with a Varian AA240Z Zeeman atomic absorption spectrometer equipped with a GTA 120 graphite tube atomizer. The polyacrylamide gels were visualized by using a BAS 2500 FUJIFILM bioimaging analyser, with the AIDA image analyser program (raytest, Germany).
Cancer cell growth inhibition
After they had been plated, human ovarian A2780 and cisplatin-resistant A2780cis cancer cells were treated with Ru II arene complexes on day 3, and human lung A549 and human colon HCT116 cancer cells were treated on day 2, at concentrations ranging from 0.1 to 100 lM. Solutions of the Ru II complexes were made up in 0.125 % dimethyl sulfoxide to assist dissolution (0.03 % final concentration of dimethyl sulfoxide per well in the 96-well plate). Cells were exposed to the complexes for 24 h, washed, supplied with fresh medium, allowed to grow for three doubling times (72 h) and then the protein content was measured (proportional to cell survival) using the sulforhodamine B assay [35] .
Reactions with GSH
(1) (100 lM) and GSH (10 mM) was incubated at 310 K in D 2 O and the changes were monitored by 1 H NMR and UV-vis spectroscopy for 24 h.
Results and discussion
Synthesis and characterization
The [(g 6 -arene)Ru(N,N 0 )X] n? complexes studied in this work are shown in Fig. 1 . The monocationic Ru II arene halido complexes 1-13 and the 9-EtG-N7 complex 14 were synthesized as PF 6 salts in good yields (more than 50 % in almost all cases). All the complexes were fully characterized by 1D and 2D 1 H NMR methods as well as 1D 13 C NMR. The molecular structures of complexes 3, 4, 6, 7 and 14 were determined by single-crystal X-ray diffraction. The molecular structure of complex 1 has been published previously [18] . Selected bond lengths and angles are given in Table 1 , the structures with numbering schemes are shown in Fig. 2 and the crystallographic data are listed in Table S1 . In all cases, the complexes adopt the familiar pseudo-octahedral three-legged piano stool geometry common to all other Ru II arene structures [36, 37] with the Ru II atom p-bonded to the corresponding arene ligand (pcym in 3 and 14; bip in 4 and 6; or etb in 7), coordinated to a chloride (4 and 7), to an iodide (3 and 6) or to N7 of 9-EtG (14) and to two nitrogen atoms of the chelating ligand bpm, which constitute the three legs of the piano stool.
The values for Ru-arene (centroid) bond lengths are comparable to those for analogous Ru II arene complexes containing N,N 0 -chelated ligands [38, 39, 76] . The nature of the corresponding N,N 0 chelating ligand, the nature of the arene and the nature of the halogen do not greatly influence the corresponding Ru-arene (centroid) distances (approximately 1.70 Å ).The corresponding Ru-I bond lengths in 3 and 6 are also within the same range (approximately 2.7 Å ) and are slightly shorter compared with those of other Ru II arene complexes containing iodide as a leaving group [40] [41] [42] . Similarly, the Ru-Cl bond lengths are almost the same (approximately 2.4 Å ). The Ru(1)-N(1) (bpm) and Ru(1)-N(8) (bpm) bond lengths in these arene complexes are approximately 2.09 Å . For the four halido complexes, the (14) , where p-cym is para-cymene, bpm is 2,2 0 -bipyrimidine, bip is biphenyl, etb is ethyl benzoate and 9-EtG is 9-ethylguanine
Ru-arene (centroid) 1.704 1.691 1.693 1.684 1.693
Ru (1) 
.64 (7) Ru-N,N 0 bond lengths are significantly longer than those found in the crystal structures of similar arene Ru II arene 2,2 0 -bipyridine (bpy) complexes [43] . The N(1)-Ru(1)-N(8) bond angles in complexes 3, 4, 6, 7 and 14 do not differ significantly from each other. In the case of complex [(g 6 -bip)Ru(bpm)Cl][PF 6 ] (4), the Ru II molecules lie backto-back with an adjacent complex in an intermolecular p-p stacking interaction (Fig. S1 ). The X-ray crystal structures of compounds 3, 4, 6 and 7 show an increased number of intramolecular and/or intermolecular p-p stacking interactions, particularly for complexes 4 and 6 (Fig. S2) , which contain bip as the arene. Their crystal packing also displays strong hydrogen bonding throughout the unit cell, which is a common feature observed in similar Ru II arene complexes containing extended aromatic rings [44, 45] . For complex 7, CH-p interactions between the C-H protons of one of the pyrazine rings in the bpm chelating ligand and the centroid of one of the pyrazine rings in the bpm (14) . Thermal ellipsoids show 50 % probability. The hydrogen atoms and counter ions have been omitted for clarity belonging to a neighbouring molecule were observed (Fig.  S3) . The occurrence of CH-p interactions is now well established [46] , and the interaction ranges from weak (CHÁÁÁp centre 2.6-3.0 Å ) to strong (CHÁÁÁp centre less than 2.6 Å ) [47] . Such interactions can play an important role in protein stability and in recognition processes. The CHÁÁÁp interactions observed for complex 7 (2.9 Å ) are within the weak-interaction range. The Ru-N7 bond distance in guanine adduct 14 [2.1125(19) Å ] is similar to the bond distances in related organometallic Ru II guanine adducts [36, 37] . There are multiple hydrogen-bonding interactions throughout the crystal. The main fragments involved are bpm, 9-EtG and solvent molecules (water; Fig. S4 ). Such aggregations have been observed in a number of Ru II and Pt II crystal structures containing purine derivatives [48] [49] [50] . Water can play an important role in intercalation modes; specific binding of water to DNA complexes can make a significant contribution to the free energy of drug binding [51] . The 9-EtG adduct (14) was also characterized by 1 H NMR spectroscopy ( Fig. S5 shows its 2D 1 H-1 H NOESY spectrum). A nuclear Overhauser enhancement cross-peak between H8 of bound 9-EtG and the 2,2 0 -H in bpm was observed, suggesting that these two atoms are in close proximity (as previously observed in analogous Ru II arene complexes) [5, 52] .
Aqueous solution chemistry
Dissolution of compounds 1-13 in 5 % MeOH/95 % H 2 O at 310 K gave rise to ligand-exchange reactions as indicated by the concomitant changes in UV-vis absorption bands. The time-evolution spectra for all the Ru II arene complexes at 310 K are shown in Fig. S6 . The time dependence of the absorbance of all the complexes at selected wavelengths followed pseudo-first-order kinetics in each case. The corresponding rate constants and halflives are listed in Fig. S7 .
To characterize the products of hydrolysis and to determine the extent of the reactions, freshly made 100 lM (5 % MeOD-d 4 /95 % D 2 O) solutions of complexes 1-13 were allowed to equilibrate for 24-48 h at 310 K and were then studied at 310 K using 1 H NMR spectroscopy. The 1 H NMR spectra of complexes 1-11 and 13 initially contained one major set of peaks (halido species), and then a second set of peaks increased in intensity with time. The new set of peaks had the same chemical shifts as those of the aqua adducts (prepared independently) under the same conditions [approximately 100 lM solutions (5 % MeOD-d 4 / 95 % D 2 O) at 310 K]. The mass-to-charge ratios and isotopic models obtained from HR-MS spectra were consistent with the formation of the aqua adducts (Table  S2) . Table 3 summarizes the equilibrium constants (calculated by integration of 1 H NMR signals) after 24 h of reaction for complexes 1-11 and 13. For complexes 4, 5, 7 and 12 an additional set of peaks was also observed H NMR spectroscopy (4, 5, 7 and 12) were determined over the period of time before the onset of arene loss. Within the series of complexes having p-cym as the arene and bpm as the chelating ligand, the hydrolysis reactions of the chlorido (1) and bromido (2) complexes are more thermodynamically favoured (K of 790.6 and 280.5 lM, respectively) compared with the hydrolysis reaction of the iodido complex (3) (K = 14.0 lM). Similarly, in the bip/bpm series, the chlorido (4) and bromido (5) complexes were hydrolyzed to a larger extent (K of 9.0 and 10.4 lM, respectively) than the analogous iodido (6) complex (K = 0.2 lM). For complexes 1, 11 and 13, where p-cym (arene) and chloride (leaving group) are kept constant but the chelating ligand is varied, the amount of aqua adduct (and equilibrium constant) determined by 1 H NMR spectroscopy increases in the order bathophen (13) \ phen (11) \ bpm (1). When the chelating ligand is bpm and the leaving group is chloride, the extent of hydrolysis decreases with the arene in the order p-cym
Complexes 2, 5, 7-9 and 11-13 undergo relatively fast hydrolysis, with half-lives of less than 60 min at 310 K. , where dha is 9,10-dihydroanthracene and en is ethylenediamine, are 10-80 times smaller than those of these complexes under comparable conditions. Within the p-cym/chloride series containing various chelating ligands, the presence of a stronger pacceptor chelating ligand reduces the electron density on the Ru II centre, making it less favourable for the chlorido ligand to leave, thus slowing down the hydrolysis reaction. Thus, the rates increase in the order 1 (bpm) \ 12 (phendio) \ 11 (phen) \ 13 (bathophen). The substituent heteroatoms on the chelating ligands (such as the extra pair of nitrogens in bpm or two oxygens in phendio), which are electron donors [54] , may contribute to stabilization of the Ru-Cl bonds by p back-donation. Previous work [55] complexes accelerates hydrolysis. Within the Ru II arene bpm/chloride series, the incorporation of arenes with either an increased aromatic character or electron-withdrawing substituents in the coordinated ring significantly decreases the rate of the hydrolysis reaction in the order
Bip has a high aromaticity and competes as a p-acceptor [56] with the chelating ligand (bpm) for electron density. This leads to a weakening of the corresponding Ru-arene bonds and consequently to the complete loss of the bip in the case of complex 4. No arene loss is observed in the case of the complexes bearing other arenes, all of which have electrondonating aliphatic substituents on the ring. A similar arene loss was previously observed for other Ru II bip complexes containing phenylazopyridines as p-acceptor ligands [57] . (X is Cl, Br or I) occurs via an associative pathway in which bond-making is more important than bond-breaking [59] .
Additionally, the changes in the 1 H NMR chemical shifts of the aromatic protons in either the corresponding arene rings or the corresponding N,N 0 chelating ligands of the aqua adducts of complexes 1, 8-11 and 13 present in an equilibrated 100 lM (D 2 O) solution at 310 K were followed with change in pH* over the range approximately 1-12. Figure S8 shows how the peaks shift to higher field owing to deprotonation of the bound water molecule in the aqua adduct of complex 1, [(g 6 -p-cym)Ru(bpm)(OH 2 )] 2? , but do not change in intensity, an indication that no other species are being formed. The pK a * values for complexes 1, 8, 9 and 11 are listed in Table 4 . For complexes 1 (p-cym/bpm), 8 (hmb/bpm), 9 (ind/bpm) and 11 (p-cym/ phen), the pK a * values are in the range from 6.91 to 7.32 and are all significantly lower (approximately 1.5 units) [7, 60] . Such a decrease in acidity has been attributed before to an increased electron density on the metal centre favoured by a combination of electron-donating/p-acceptor-arene/chelating ligands. Complexes 1, 8, 9 and 11 will therefore be present as a mixture of aqua and (less reactive) hydroxido adducts at pH 7.4.
Hydrolysis mechanism
DFT computational methods were employed to obtain information about the influence of the leaving group on the mechanism of hydrolysis for the p-cym/bpm series of Ru II arene complexes 1-6. A test of the structural accuracy of the functional PW91 with COSMO solvation was performed by comparing the fully optimized structures of the cations in complexes 1-6 with the corresponding X-ray crystal structures of 1 [18] , 3, 4 and 6. The functional PW91 was found to overestimate the Ru II bond lengths by approximately 0.01-0.04 Å , particularly for the computed Ru-X distances (approximately 2.44 Å ), which were approximately 0.05 Å longer than those found in the solid state. However, the overall agreement with the experimental data was satisfactory. A scheme for the reaction modeled is shown in Fig. 3 ? is shown in Fig. 4 . The geometry-optimized structure in the transition state of the Ru II arene cation in complex 1 gave Ru-Cl and Ru-OH 2 bond distances of 3.11 and 2.68 Å , respectively. The corresponding energy value determined for the transition state (-6,657.51 kcal mol -1 ) was 20.1 kcal mol -1 larger than that for the chlorido compound in the resting state. Given that the hydrolysis reaction could be assumed to be an associative, a dissociative, or an interchange (I a or I d ) process, a frequency calculation was performed for the transition state of the Ru II arene cation in complex 1. Two imaginary frequencies were retrieved from the computation, -152 and -20 cm . The latter is small and arises from the numerical noise inherent in the finite difference method required when a COSMO field is enabled. The former (and more significant) frequency value (-152 cm -1 ) gave a vibrational mode where the entering water molecule and leaving halido ligand (Cl -) are moving in a concerted process consistent with an associatively activated reaction. The corresponding scaled displacement vectors are shown in Fig. S9 . Under the assumption that the same associative hydrolysis mechanism applies for other related systems, the effects of varying X and the arene were explored. The results are listed in Table 5 , from where it can be seen that the corresponding barrier heights do not vary significantly when the arene p-cym (in complexes 1-3) is replaced by bip (in complexes 4-6). complexes, where arene is p-cym (1-3) or bip (4-6) and X is Cl, Br or I, proceeds via a concerted interchange (associative) mechanism rather than a stepwise dissociation/ coordination process (dissociative). For the p-cym/bpm series of complexes (1-3), the reaction does not appear to be strongly associatively or dissociatively activated, because the corresponding Ru-X bonds at the transition state extend by approximately 0.66, 0.71 and 0.81 Å for Cl, Br, and I, respectively, relative to the reactant species. In (4-6) showed that the hydrolysis might not be strongly associatively nor dissociatively activated either. The corresponding Ru-X bonds at the transition state extend by approximately 0.58, 0.61 and 0.69 Å for Cl, Br and I, respectively, relative to the reactant species, whereas the Ru-O bonds in the transition state were found to be approximately 0.55 Å longer than in the aqua products. Given that Ru-X bond-breaking alone is not the rate-controlling step in the associative pathway, a heavier (and larger) halide will impede the access of the H 2 O molecule to the central Ru II atom in associative states. This hypothesis is in good agreement with the experimental observation that complexes 3 and 6 (bearing iodide as the leaving group) display the slowest rates of hydrolysis within the corresponding series. This assumption has also been suggested for ruthenium complexes displaying higher coordination numbers (i.e. seven) [61, 62] . The calculated reaction barriers and overall reaction energies for the aquation of the halido complexes 1-6 follow the increasing order Cl & Br \ I. However, the effect of different halides on the experimental hydrolysis rates of these Ru II arene complexes differs from the calculation and follows the increasing order Br \ Cl \ I. This trend has been experimentally observed before for platinum compounds of the type [PtX n (OH 2 ) 4-n ] (2-n)? , for which Br analogues of Cl complexes hydrolyze faster in all three hydrolysis steps [38, 39] . The calculated higher activation energies might be responsible for the observed slower hydrolysis of the iodido complexes during the associative ligand interchange in each series. Furthermore, the electron-accepting effect of strong p-acid arene ligands ? complexes studied herein. The accuracy of the calculation was not sufficient to account for the differences found experimentally in the hydrolysis rates between the chlorido and bromido complexes.
Interactions with nucleobases
Interactions of several complexes with 9-EtG and 9-EtA were studied by multidimensional 1 H NMR spectroscopy and the nature of the products was verified by HR-MS. All the reactions were performed in NMR tubes in D 2 O and followed over 48 h at 310 K. Figure 5 shows the reaction of complex 11 with 9-EtG as an example. The 1 H NMR peaks corresponding to H8 in all the 9-EtG-N7 adducts are shifted to high field (approximately 0.5 ppm) relative to free 9-EtG under the same conditions. Often, metallation at the N7 site of purine bases (Fig. 6 ) produces a low-field shift of the H8 resonance by about 0.3-1 ppm [63, 64] . This effect has also been observed before for analogous Ru II arene complexes containing bpy or acac [6] as the chelating ligand. The compounds studied in this work showed significant and rapid binding to 9-EtG-N7 (detectable after approximately 10 min and to an extent of approximately 34-94 %). (8) and [(g 6 -ind)Ru(bpm)Cl)] ? (9) , which reacted with 9-EtG much faster, reaching equilibrium after 56 and 52 min, respectively. Table S6 lists the percentage of species present in solution for the reactions of complexes 1, 8-11 and 13 with 9-EtG after selected times. The reactions of complexes 8, 9 and 10 with 9-EtG produced higher yields. Interestingly, for complex 10, approximately 12 % of a second guanine-bound species (possibly [(g 6 -thn)Ru(bpm)(9-EtG-N3)] 2? ) was also detected at equilibrium (approximately 510 min; Fig. S10 ). The mass-to-charge ratios and isotopic models obtained from HR-MS spectra were consistent with the formation of the guanine adducts as the corresponding products of the individual reactions (Table S3 ). The addition of an equimolar amount of 9-EtA (100 lM) to freshly prepared D 2 O solutions of the complexes at 310 K resulted in no new species even after 48 h.
Since nucleobase binding is likely to require initial hydrolysis, the slow aquation rates and reduced extent of hydrolysis of these complexes at equilibrium may account for the observed extent of nucleobase binding. The calculated binding energies for 9-EtG in the corresponding nucleobase adducts appear to be related to the trend determined for the extent of nucleobase binding (vide infra). None of the Ru II arene complexes 1, 8-11 and 13 showed evidence of binding to 9-EtA. These complexes display a more discriminating behaviour towards binding to purine bases when compared with cisplatin, for which binding to adenine is also observed [65] . It has been found that hydrogen bonding from C6O in guanine to N-H protons in the bidentate chelating ligand ethylenediamine 
2? , stars phen, circles p-cym, diamond bound 9-EtG-N7 contributes to the high preference for binding of {(g 6 -arene)Ru(en)} 2? to guanine versus adenine. However, replacement of ethylenediamine (NH as a hydrogen-bond donor) by bpm (no NH) in these series of complexes did not change the selectivity for guanine bases.
To gain further insight into the nature and relative stabilities of the guanine and adenine adducts of Ru II arene complexes 1, 8-11 and 13, their optimized geometries were obtained using DFT calculations. Their minimum-energy structures are shown in Figs. S11 and S12 (for the 9-EtG-N7 and 9-EtA-N7 adducts, respectively). The total binding energies for both nucleobases are shown in Table 6 . The binding energies include a COSMO contribution which simulates an aqueous environment. Under these conditions, the binding of 9-EtG was more favourable than that of 9-EtA by approximately 10.0 kcal mol -1 . Furthermore, the nucleobase 9-EtG shows significant binding energies for all compounds (38.5 kcal mol -1 or greater), the largest value being for the adduct [(g 6 -thn)Ru(bpm)(9-EtG-N7] 2? (10-9-EtG), with a value of 41.0 kcal mol -1 . In the case of 9-EtA, a smaller binding energy for all compounds 34.4 kcal mol -1 or less) was found; the largest energy was calculated for the adduct [(g 6 -thn)Ru(bpm)(9-EtA-N7] 2?
(10-9-EtA). The binding of 9-EtG to the N3 position in complex 10 was also investigated. The minimum-energy structures are shown in Fig. S13 for the 9-EtG-N7 and 9-EtG-N3 adducts. The calculated total binding energies are 41.0 and 18.5 kcal mol -1 for the 9-EtG-N7 and the 9-EtG-N3 adduct, respectively.
Despite the lack of cytotoxic activity, compounds 1 and 8-10 showed a significant calculated binding energy for 9-EtG-N7 (approximately 38.8 kcal mol -1 ). As would be expected, the binding of 9-EtG to complex 10 through N7 is approximately 20 kcal mol -1 more stable than the binding through N3. The calculations were also able to reproduce the hydrogen-bond distance (CH (N,N 0 -chelating) ÁÁÁO (9-EtG) ) found in the X-ray crystal structure of the 9-EtG adduct, complex 14, within sufficient accuracy. Therefore, it is assumed that the analogous values from the DFT-optimized geometries for the rest of the 9-EtG adducts of complexes 1, 8-11 and 13 will also be within the expected ranges. The calculations predict CH (N,N 0 -chelating) ÁÁÁO (9-EtG) distances within the range from 2.20 to 3.11 Å and C-H (N,N 0 -chelating) ÁÁÁO angles within the range from 114.93°to 134.97°. The shortest hydrogenbond distance was found for the 9-EtG adduct of complex 10, which might explain the high binding energy calculated for this adduct. Table 7 . Both complexes reacted with CT-DNA to a moderate extent and the reactions were complete after approximately 20 h. Complex 11 bound much faster and to a larger extent than complex 1, with equilibrium for complex 11 being reached within the first 1.5 h. After 24 h of reaction, both complexes had reacted to a similar extent, approximately 60 % (Fig. S14) . Dialysis against two different sodium salts indicated that the coordination of the Ru II arene complexes to CT-DNA is reversible and dependent on the nature of the salt. In the case of complex 11, dialysis against either 10 mM NaClO 4 Fig. 7 . The bands corresponding to the transcription of DNA modified by complexes 1 and 11 yielded fragments of newly synthesized RNA of defined sizes, which indicates that RNA synthesis on these templates was prematurely terminated. The major stop sites occurred at similar positions in the gel and were solely at guanine residues, for both Ru II arene complexes (Fig. 8) . The intensities of the bands corresponding to the transcription of DNA modified by complex 11 are considerably weaker than those of the bands corresponding to the transcription of DNA modified by complex 1 (Fig. 7) . This may indicate that the efficiency of DNA adducts of 11 to prematurely terminate RNA synthesis by T7 RNA polymerase is lower than that of DNA adducts of 1. We can speculate that this reduced efficiency is associated with lesser distortion of the DNA conformation exerted by DNA adducts of 11 (compared with DNA adducts of 1) as deduced from the results of CD spectroscopy of DNA modified by these complexes (Fig. 10) . Another possibility might be through the labilization of DNA-metal adducts by the phen chelating ligand in 11 being greater than that exerted by the bpm chelating ligand in 1 owing to the introduction of electron-withdrawing substituents in the 4,4 0 positions of bpm in complex 11 (which contains phen as a chelating ligand). As a consequence, some molecules of 11 originally bound to DNA might be displaced by T7 RNA polymerase during transcription of the template strand containing them and consequently would be unable to prematurely terminate RNA synthesis by this enzyme. The labilization of other metal-biologically relevant molecules by spectator ligands (in metal complexes) has already been demonstrated for Pt II complexes [66] . The rate of binding to DNA for complex 1 is slower than that determined for the anticancer drug cisplatin (t 1/2 Fig. 8 The portion of the sequence used to monitor inhibition of RNA synthesis by Ru II arene complexes. The arrow indicates the start of the T7 RNA polymerase, which used as a template the bottom strand of the NdeI/HpaI fragment of pSP73KB. The filled circles represent major stop sites for DNA modified by complex 1 or complex 11, respectively. The numbers correspond to the nucleotide numbering in the sequence map of the pSP73KB plasmid approximately 2 h under similar conditions) [67] , for which DNA binding is thought to be responsible for its cytotoxic properties. Interestingly, the corresponding binding rate for complex 11 was found to be in the same range as that of cisplatin. In contrast, other Ru II arene analogues, e.g. [(g 6 -bip)Ru(en)Cl] ? , which has also been shown to be toxic to cancer cells [38, 39, 68, 69] Fig. 9 . The DNA unwinding angles produced by the adducts of 1 and 11 were determined to be 7.7°and 6.6°, respectively, which is consistent with only a small reduction of the intensity of the negative CD band at approximately 245 nm of DNA modified by 1 or 11 (vide infra) [70, 71] . This DNA unwinding angle is smaller than that observed for other Ru II arene complexes [(g 6 -arene)Ru(en)Cl] ? (range from 7°to 14°) [42] and resembles more DNA unwinding angles produced by monofunctional cisplatin adducts (6°) [34] .
The co-migration point of the modified supercoiled and nicked DNA r b (c) was reached at r b values of 0.13 and 0.15 (for 1 and 11, respectively) as shown in Table 8 .
CD spectra of CT-DNA modified by complexes 1 and 11 (at 298 K in 10 mM NaClO 4 ) were also recorded at r b values in the range from 0.013 to 0.047. As can be seen from Fig. 10 , small changes in the CD spectrum at wavelengths below 300 nm are observed upon interaction of complex 1 (and to a much lesser extent of complex 11) with CT-DNA. As a consequence of the ruthenation of CT-DNA, the intensity of the positive CD band at around 280 nm increases for complex 1, whereas the CD spectrum recorded for CT-DNA modified by 11 remains unchanged. The signature of complexes 1 and 11 bound to CT-DNA includes no isothermal CD. The changes in the CD spectra of CT-DNA (monitored at 246 and 278 nm) modified by Ru II arene complexes 1 and 11 (at different r b values) are shown in Table S4 .
The CD spectra showed that the binding of 1 (and to a lesser extent of 11) to DNA results in subtle conformational alterations in DNA that could be related to a denaturational character, similar to those induced in DNA by clinically ineffective transplatin. It is possible that these changes could also be associated with the bound Ru II arene fragment given that these Ru II arene complexes show maxima in the proximity of a DNA maximum.
Overall, these combined results might suggest the presence of combined covalent (coordinative), noncovalent intercalative, and monofunctional coordination binding modes of DNA binding for complexes 1 and 11 upon hydrolysis.
Binding of the Ru II arene complexes to CT-DNA was also monitored by LD spectroscopy. It is well established that the magnitude of the LD signal measured within the DNA absorption band (i.e. at the 258-nm maximum) is a function of its persistence length [72] [73] [74] [75] . The magnitudes of the LD signals at 258 nm decrease as a function of r b for Ru II arene complexes 1 and 11 (Fig. 11) . The changes in the LD spectra of CT-DNA modified by the Ru II complexes at different r b values were monitored at 258.5 nm (Table S5 ). It can be seen that both complexes behave similarly and their changes are within the same range. These results might suggest that the formation of DNA adducts could be eventually accompanied by the appearance of flexible hinge joints at the site of the lesion.
Cancer cell growth inhibition
Halido complexes 1-6 ( Fig. 1) were tested against the A2780 human ovarian, A2780 cisplatin-resistant human ovarian, A459 human lung, and HCT116 human colon cancer cell lines, whereas the remaining halido complexes, 8-11 and 13, were tested against the A2780 human ovarian Cisplatin 0.08 13.0 ± 0.4 Fig. 9 The unwinding of supercoiled pUC19 plasmid DNA by complexes 1 (top) and 11 (bottom). The plasmid was incubated with Ru II arene complexes in 10 mM NaClO 4 , at pH 6 for 24 h at 310 K. 50 values larger than 100 lM with regard to the corresponding cell lines tested (the IC 50 value for cisplatin was 1.0 lM under the same conditions). Complexes 11 and 13, bearing phen and bathophen as the chelating ligand, respectively, were cytotoxic to A2780 human ovarian cancer cells ( ? when ethylenediamine, a r-donor, is replaced by bpy [76] , a strong p-acceptor. Changing the electronic features of the chelating ligands by incorporating electron-donating heteroatoms in the 4,4 0 positions of bpm (such as in the phendio complex 12) did not restore the cytotoxic activity. From a structural point of view, loss of activity in these derivatives could arise from the absence of N ðsp 3 Þ H groups, which are known to stabilize nucleobase adducts through strong hydrogen bonding between an NH of ethylenediamine and C6O from the guanine nucleobase [77] . The electronic properties of the complexes might also account for the observed loss of activity; metal-DNA bonds have been shown to be labilized by heteroarene ligands. After replacement of two water molecules by thiourea for instance, labilization of the Pt-N bond in the trans position forms a ring-opened trisubstituted [Pt(tu) 3 (N-N open ) ] 2? species (where tu is thiourea) [67] . Similar reactions are also known in the biotransformation pathway of cisplatin, where the resulting products are inert to further substitution reactions and therefore limit the active concentration of the drug [78] .
Interactions with GSH 1 H NMR and UV-vis absorption spectra of solutions containing the inactive complex [(g 6 -p-cym)Ru(bpm) Cl][PF 6 ] (1) (100 lM) and a 100-fold molar excess of GSH (10 mM, to mimic intracellular conditions) were acquired over 24 h at 310 K. The time-evolution spectra for Ru II arene complex 1 are shown in Fig. S15 . The 1 H NMR spectra of complex 1 initially contained one major set of peaks (chlorido species) and then a second set of peaks assignable to the aqua adduct [(g 6 -p-cym)Ru(bpm)OH 2 ] 2? , which increased in intensity with time. A third set of peaks attributable to the GS-bound ruthenium adduct [(g 6 -pcym)Ru(bpm)GS]
? (1-GS; Fig. 12 ) was also detected. The mass-to-charge ratio and isotopic model obtained from HR-MS spectra were consistent with the formation of the tripeptide-substituted Ru II product, and the calculated m/z value for C 28 H 36 N 7 O 6 RuS (700.1508); found m/z (700.1493). Some sulfur-bound thiolate adducts with platinum anticancer drugs are formed irreversibly and are also largely unreactive (e.g. towards DNA binding) [79] . 
Conclusions
)] at 310 K. DFT calculations on bpm complexes 1-6 suggest that aquation occurs via a more associative pathway in an I a $ I d mechanistic continuum for which bond-making is of greater importance than bond-breaking. For both p-cym and bip bpm-containing complexes 1-6, the calculated reaction barriers and overall reaction energies follow the order I [ Br & Cl, which may explain the slow hydrolysis rate determined by UV-vis spectroscopy for iodido complexes 3 and 6.
In general, we were not able to establish a correlation between hydrolysis rates and anticancer activity, which implies that the mechanism of action for these series of complexes does not depend solely on this process. The half-sandwich Ru II arene complexes containing phen (11) or bathophen (13) as N,N 0 chelating ligands are more cytotoxic towards A2780 human ovarian cancer cells, in contrast to the analogous complexes containing bpm (1-6). X-ray crystal structures show that bip complexes (4 and 6) can form strong interligand and intraligand p-p interactions, which enforces planarity on the bpm ligand, particularly in the case of complex 4. An interesting feature of the structure of complex 7 is the presence of aromatic CH-p (bpm) interactions. Strong binding to 9-EtG, but not to 9-EtA, was observed for complexes containing N,N 0 chelating ligands such as bpm, phen and bathophen, as well as different arenes such as p-cym, hmb, ind and thn. By the use of DFT calculations, the binding energies for model DNA nucleobases were assessed. DFT calculations show that the 9-EtG nucleobase adducts of all complexes are thermodynamically preferred compared with their 9-EtA adducts by approximately 10 kcal mol -1 , explaining the guanine-specific binding observed experimentally for complexes 1, 8-11 and 13. DNA binding studies show that complexes 1 and 11 bind to DNA, suggesting that it could be a target for these complexes, although the induced conformational changes are not significant. The reduced cytotoxic potency of the bpm-containing complexes might be due to the weakness of lesions on DNA or side reactions with other biomolecules such as GSH. The formation of a presumably largely unreactive Ru II -GS adduct might contribute to the lack of cytotoxicity [79] . 
